Healthcare -
Biotechnology - NASDAQ - US
$ 29.3
-1.31 %
$ 1.73 B
Market Cap
-22.89
P/E
JANX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities JANX - Janux Therapeutics, Inc.
713 M
LAST VALUE
3676.86%
2 YEAR CAGR
181.99%
5 YEAR CAGR
0.00%
10 YEAR CAGR